Continued momentum is forecast for cannabis regulation in 2026, especially on federal rescheduling of marijuana from Schedule I to Schedule III following executive actions and prior Health & Human Services recommendations, though litigation may slow progress. The consumable hemp industry may survive but with reduced scope, dominated by low-THC/CBD products. State markets will largely stay the same as operators prepare for change, and a potential Supreme Court ruling could affect gun rights for marijuana users.
